• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

作者信息

Karthikeyan G, Eikelboom J W

机构信息

All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

出版信息

Thromb Haemost. 2010 Jul;104(1):45-8. doi: 10.1160/TH09-11-0757. Epub 2010 May 10.

DOI:10.1160/TH09-11-0757
PMID:20458437
Abstract
摘要

相似文献

1
The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?用于心房颤动中风风险分层的CHADS2评分——是友还是敌？
Thromb Haemost. 2010 Jul;104(1):45-8. doi: 10.1160/TH09-11-0757. Epub 2010 May 10.
2
Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.进退两难——权衡华法林对老年房颤患者的风险与潜在益处。
Age Ageing. 2004 Nov;33(6):544-7. doi: 10.1093/ageing/afh211.
3
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
4
Anticoagulation in the octogenarian with atrial fibrillation.八十岁房颤患者的抗凝治疗
Med Health R I. 2009 Apr;92(4):152-4.
5
Stroke in heart failure: atrial fibrillation revisited?心力衰竭中的中风：重新审视心房颤动？
J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002.
6
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
7
Bleeding risk on warfarin among elderly patients with atrial fibrillation.老年房颤患者服用华法林后的出血风险
J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.
8
Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.高龄房颤患者服用华法林时的出血风险：与衰老及CHADS2评分的关系
Thromb Res. 2007;121(3):347-52. doi: 10.1016/j.thromres.2007.05.014. Epub 2007 Jun 26.
9
Identifying AF patients at risk of stroke: can prothrombotic indices improve things?识别有中风风险的房颤患者：血栓前状态指标能有所帮助吗？
Int J Cardiol. 2008 Jun 6;126(3):299-301. doi: 10.1016/j.ijcard.2007.08.092. Epub 2008 Feb 20.
10
Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.心房颤动的卒中风险评估：基于医院的卒中风险评估和干预计划。
J Clin Pharm Ther. 2011 Feb;36(1):71-9. doi: 10.1111/j.1365-2710.2009.01156.x.

引用本文的文献

1
Does CHA2DS2-VASc score predict mortality in chronic kidney disease?CHA2DS2-VASc 评分能否预测慢性肾脏病患者的死亡率？
Intern Emerg Med. 2021 Oct;16(7):1737-1742. doi: 10.1007/s11739-021-02799-5. Epub 2021 Jul 7.
2
Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation.分析非瓣膜性心房颤动患者左心房/左心耳血栓形成的危险因素。
Cardiovasc J Afr. 2021;32(3):116-122. doi: 10.5830/CVJA-2019-071. Epub 2021 Apr 16.
3
Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
中低收入国家的心房颤动长期口服抗凝治疗。
Indian Heart J. 2021 Mar-Apr;73(2):244-248. doi: 10.1016/j.ihj.2021.02.003. Epub 2021 Feb 10.
4
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.当代心房颤动患者预防卒中的抗血栓治疗应用情况：澳大利亚医院环境下的一项审计
Ther Adv Drug Saf. 2018 Feb;9(2):97-111. doi: 10.1177/2042098617744926. Epub 2017 Dec 13.
5
Preventative Measures of Stroke in Patients With Atrial Fibrillation.心房颤动患者中风的预防措施
J Atr Fibrillation. 2012 Apr 14;4(6):399. doi: 10.4022/jafib.399. eCollection 2012 Apr-May.
6
Stroke Prevention in Atrial Fibrillation.心房颤动的卒中预防
J Atr Fibrillation. 2010 Oct 22;3(3):279. doi: 10.4022/jafib.279. eCollection 2010 Oct-Nov.
7
Stroke And Bleeding Risk Assessment: Where Are We Now?中风与出血风险评估：我们目前的进展如何？
J Atr Fibrillation. 2014 Apr 30;6(6):1042. doi: 10.4022/jafib.1042. eCollection 2014 Apr-May.
8
The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.印度心房颤动卒中预防共识指南：重点关注非维生素K口服抗凝剂的实际应用。
Indian Heart J. 2015 Dec;67 Suppl 2(Suppl 2):S13-34. doi: 10.1016/j.ihj.2015.10.380. Epub 2015 Nov 24.
9
Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.华法林在房颤透析患者中的有效性和安全性：观察性研究的荟萃分析
Medicine (Baltimore). 2015 Dec;94(50):e2233. doi: 10.1097/MD.0000000000002233.
10
Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin.新型非瓣膜性心房颤动患者接受达比加群酯或华法林治疗后的住院治疗、费用和 30 天内再入院情况。
J Manag Care Spec Pharm. 2015 Nov;21(11):1039-53. doi: 10.18553/jmcp.2015.21.11.1039.